Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Aliment Pharmacol Ther ; 59(11): 1387-1401, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38501893

ABSTRACT

BACKGROUND: Results of studies evaluating the effect of viral eradication following direct-acting antiviral (DDA) therapy on skeletal muscle mass of patients with chronic hepatitis C (CHC) are scarce. AIM: To assess the components of sarcopenia (low muscle mass, low muscle strength and low physical performance) in a cohort of CHC individuals before and after DAA therapy. METHODS: We performed a longitudinal study of patients with CHC who underwent body composition assessment before (T0), and at 12 (T1) and 48 (T2) weeks after DDA therapy. Bioelectrical Impedance Analysis was used to assess skeletal mass muscle (SM) and phase angle (PhA). SM index (SMI) was calculated by dividing the SM by squared height. Muscle function was evaluated by hand grip strength (HGS) and timed up-and-go (TUG) test. Mixed-effects linear regression models were fitted to SMI, HGS and physical performance and were used to test the effect of HCV eradication by DAA. RESULTS: 62 outpatients (mean age, 58.6 ± 10.8 years; 58% with compensated cirrhosis) were included. Significant decreases in liver fibrosis markers and an increase of 0.20 and 0.22 kg/m2 in the SMI were observed at T1 and T2. Following DAA therapy, an increase of one unit of PhA was associated with a reduction of 0.38 min in TUG. CONCLUSION: HCV eradication with DAA therapy was associated with a dynamic reduction of non-invasive markers of liver fibrosis and increased muscle mass in 62 patients with CHC who had an undetectable HCV load at 12 weeks after completion of antiviral treatment.


Subject(s)
Antiviral Agents , Body Composition , Hepatitis C, Chronic , Muscle, Skeletal , Sarcopenia , Humans , Hepatitis C, Chronic/drug therapy , Antiviral Agents/therapeutic use , Male , Middle Aged , Female , Longitudinal Studies , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiopathology , Aged , Sarcopenia/drug therapy , Body Composition/drug effects , Hand Strength , Muscle Strength/drug effects , Liver Cirrhosis/drug therapy , Liver Cirrhosis/virology
3.
Biol Reprod ; 80(3): 537-44, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19020298

ABSTRACT

The Nile tilapia (Oreochromis niloticus) is economically one of the most important freshwater fish and is an excellent model for studies under laboratory conditions. Temperature is considered a very important modulator of reproductive activity in fish, although few studies have specifically addressed the effects of this key factor on morphological and functional aspects of teleost testes. Therefore, our main objectives in the present study were to analyze the effects of different temperatures (20, 25, 30, and 35 degrees C) on testicular somatic and germ cells in sexually mature Nile tilapias. Compared with fish kept at other temperatures, tilapias maintained at 20 degrees C demonstrated increased (P < 0.05) Sertoli cell and Leydig cell proliferation, volume density and frequency of most type B spermatogonia, and germ cell apoptosis. Conversely, tubular fluid secretion was decreased (P < 0.05) in the same animals. Although not significant, type A spermatogonia proliferation followed the pattern established for Sertoli cell and Leydig cell mitotic activity, suggesting that they preferentially would proliferate at lower temperatures. Based on most results found in our study and considering that tilapias are nonseasonal breeders, we suggest a model for temperature action on tilapia testes in which lower temperature (20 degrees C) would favor type A spermatogonial renewal, Sertoli cell and Leydig cell proliferation, and germ cell apoptosis, whereas higher temperatures (30-35 degrees C) would trigger rapid germ cell differentiation. Thus, tilapias could potentially be utilized in studies involving hormones and factors related to Sertoli cell and Leydig cell proliferation and spermatogonial self-renewal or differentiation.


Subject(s)
Germ Cells/physiology , Leydig Cells/physiology , Sertoli Cells/physiology , Temperature , Testis/cytology , Testis/physiology , Tilapia/physiology , Animals , Apoptosis/physiology , Cell Proliferation , Germ Cells/cytology , Leydig Cells/cytology , Male , Sertoli Cells/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...